Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives

Journal of Pharmacological Sciences

Volumn 100, Issue 5, 2006, Pages 513-518

  Satoh, Mitsutoshi ^a   Takayanagi, Issei ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Anti tumor; Nerve protection; Nitric oxide; Smooth muscle

Indexed keywords

DOPAMINE; ENZYME; FULLERENE DERIVATIVE; LEVODOPA; NUCLEIC ACID; ACETYLCHOLINE; CARBON; NITRIC OXIDE;

ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; BIOTECHNOLOGY; CARDIOVASCULAR SYSTEM; CHONDROGENESIS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG SYNTHESIS; MORPHOGENESIS; MUSCLE CONTRACTION; NEUROPROTECTION; NONHUMAN; REVIEW; SKIN TUMOR; SOLUBILITY; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DRUG ANTAGONISM; HUMAN; MUSCLE RELAXATION;

ACETYLCHOLINE; ANIMALS; CARBON; FULLERENES; HUMANS; MODELS, BIOLOGICAL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; SOLUBILITY;

EID: 33747611256     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.CPJ06002X     Document Type: Review

References (31)

1. 60: buckministerfullerene. Nature. 1985;318:162-163.
2. Nakajima-Yamakoshi Y, Yagami T, Fukuhara K, Sueyoshi S, Miyata N. Solubilization of fullerenes into water with polyvinylpyrrolidone applicable to biological tests. J Chem Soc, Chem Commun. 1994;517-518.
3. Jensen AW, Wilson SR, Schuster DI. Biological applications of fullerenes. Bioorg Med Chem. 1996;4:767-779.
4. 70. Nature. 1993;361:138-140.
5. Tokuyama H, Yamago S, Nakamura E. Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc. 1993;115:7918-7919.
6. Sijbesma R, Srdanov G, Wudl F, Gastoro JA, Wilkins C, Friedman SH, et al. Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J Am Chem Soc. 1993;115:6510-6512.
7. Chen B-X, Wilson SR, Das M, Couglin DJ, Erlanger BF. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci U S A. 1998;95:10809-10813.
8. Scrivens WA, Rawlett AM, Tour JM. Preparative benchtop enrichment of C(60), C(70), and the higher fullerene allotropes using a brominated polystyrene stationary phase. J Org Chem. 1997;62:2310-2311.
9. 60 on agonists-induced responses in various tissues of guinea-pig and rat. Gen Pharmacol. 1995;26:1533-1538.
10. 60, on nitric oxide-dependent relaxation of aortic smooth muscle. Gen Pharmacol. 1997;29:345-351.
11. 60, on nitric oxide-induced relaxation of rabbit aorta. Eur J Pharmacol. 1997;327:175-181.
12. 60 derivatives on endothelium-derived relaxation in rabbit thoracic aorta. Fullerene Sci Tech. 2001;9:141-151.
13. 60-fullerene adducts. Arch Biochem Biophys. 2000;378:216-223.
14. 22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett. 2005;5:2050-2057.
15. Nelson MA, Frederick K, Domann E, Bowden TG, Hooser SB, Fernando Q, et al. Effects of acute and subchronic exposure of topically applied fullerene extracts on the mouse skin. Toxcol Industrial Health. 1993;9:623-630.
16. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1968;13:222-257.
17. Mian KB, Martin W. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by super oxide anion in rat aorta. Br J Pharmacol. 1995;115:993-1000.
18. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 1992;263:H257-H265.
19. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 1993;364:626-632.
20. 2. J Am Chem Soc. 2003;125:12803-12809.
21. 24. Nitric Oxide. 2004;11:201-207.
22. 60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. J Pharm Pharmacol. 1997;49:438-445.
23. 60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity. J Neurosci Res. 2003;71:121-126.
24. Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci. 1999;19:1284-1293.
25. Greenlund LJS, Deckwerth TL, Johnson EM Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 1995;14:303-315.
26. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A. 1997;94:2642-2647.
27. 3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. J Neurochem. 2000;74:1197-1204.
28. 60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun. 1995;206:885-894.
29. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 1996;393:139-145.
30. Marchesan S, Da Ros T, Spalluto G, Balzarini J, Prato M. Anti-HIV properties of cationic fullerene derivatives. Bioorg Med Chem Lett. 2005;15:3615-3618.
31. Mashino T, Shimotohno K, Ikegami N, Nishikawa D, Okuda K, Takahashi K, et al. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Bioorg Med Chem Lett. 2005;15:1107-1109.